• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,991.22 790.54
( 1.04%)
Global Indices
Nasdaq
51,704.04 -29.67
(-0.06%)
Dow Jones
7,389.07 -104.72
(-1.40%)
Hang Seng
69,343.30 -445.08
(-0.64%)
Nikkei 225
10,453.87 25.02
(0.24%)
Forex
USD-INR
94.53 0.21
(0.22%)
EUR-INR
108.18 0.03
(0.03%)
GBP-INR
125.09 0.39
(0.31%)
JPY-INR
0.58 0.00
(0.06%)

EQUITY - MARKET SCREENER

Sunrest Lifescience Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
91669
INE0PLZ01012
27.4543251
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNREST
9.04
27.94
EPS(TTM)
Face Value()
Div & Yield %
3.6
10
0
 

wanbury ltd
Vimta Labs standalone net profit rises 15.23% in the March 2026 quarter
May 06,2026
Net profit of Vimta Labs rose 15.23% to Rs 21.11 crore in the quarter ended March 2026 as against Rs 18.32 crore during the previous quarter ended March 2025. Sales rose 15.68% to Rs 109.25 crore in the quarter ended March 2026 as against Rs 94.44 crore during the previous quarter ended March 2025.

For the full year,net profit rose 15.10% to Rs 77.51 crore in the year ended March 2026 as against Rs 67.34 crore during the previous year ended March 2025. Sales rose 18.41% to Rs 407.29 crore in the year ended March 2026 as against Rs 343.98 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales109.2594.44 16 407.29343.98 18
OPM %36.0334.99 -34.7535.45 -
PBDT41.7934.24 22 149.34124.29 20
PBT29.0425.03 16 105.5789.00 19
NP21.1118.32 15 77.5167.34 15